|
RECENT
PUBLICATIONS
Decisional
conflict among patients who accept or decline participation in phase
I oncology studies.
Flynn KE et al. J Empir Res Hum Res
Ethics. 2008;3:69-77.
Cost-effectiveness
of the oral adsorbent AST-120 versus placebo for chronic kidney
disease.
Takahashi T et al. Nephrology (Carlton).
2008;13:419-427.
Use
of smaller versus larger drug-safety databases before regulatory
approval: the trade-offs.
Reed SD et al. Health Aff (Millwood).
2008;27:w360-w370.
Expectations
of benefit in early-phase clinical trials: implications for assessing
the adequacy of informed consent.
Weinfurt KP et al. Med Decis Making.
2008;28:575-581.
Identification
of patients with diabetic macular edema from claims data: a validation
study.
Bearelly S et al. Arch Ophthalmol.
2008;126:986-989.
Association
between the Medicare Modernization Act of 2003 and patient wait
times and travel distance for chemotherapy.
Shea AM et al. JAMA. 2008;300:189-196.
Sensitivity
of International Classification of Diseases codes for hyponatremia
among commercially insured outpatients in the United States.
Shea AM et al. BMC Nephrol. 2008;9:5.
|
|
FEATURE
Which
drugs are on the Beers list of potentially inappropriate
medications for the elderly?
PUBLICATIONS
Complete
CCGE Bibliography
May 19, 2008
PEPC
Briefs
Reviews of recent articles in pharmaceutical economics and policy.
|
